Literature DB >> 10785838

Neurophysiology of sensorimotor integration in Parkinson's disease.

P M Rossini1, M M Filippi, F Vernieri.   

Abstract

Parkinson's disease (PD) is a major neurologic disorder that distinctively and selectively affects movement and--by extension--the motor system. A large body of evidence has been accumulated over the years showing that movement disorders of PD are also due to sensory disturbances that affect sensorimotor integration. The aim of this review is to discuss the possible contribution of neurophysiologic techniques in evaluating the functionality of sensorimotor integration mechanisms in PD. Somatosensory evoked potentials (SEPs) are an appropriate functional approach for the evaluation of sensory processes in the human brain. SEPs from the frontal scalp sites are considered markers of the functionality of a cortico-subcortico-cortical loop that includes the basal ganglia as well as the premotor and supplementary motor areas. Over the years, it has been demonstrated that PD patients--especially in the early stages of the disease--show a severely depressed frontal responsiveness to sensory stimuli as tested via SEPs. The transient recovery of frontal SEP amplitude after apomorphine, a potent dopamine agonist drug, is a good and specific predictor of the clinical response of PD patients to L-dopa therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10785838

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  5 in total

1.  Analysis of complexity in the EEG activity of Parkinson's disease patients by means of approximate entropy.

Authors:  Chiara Pappalettera; Francesca Miraglia; Maria Cotelli; Paolo Maria Rossini; Fabrizio Vecchio
Journal:  Geroscience       Date:  2022-03-28       Impact factor: 7.581

2.  Late-onset choreoathetotic syndrome following heart surgery.

Authors:  Maria Grazia Passarin; Silvia Romito; Mirko Avesani; Franco Alessandrini; Giuseppe Petrilli; Francesco Santini; Laura Bertolasi; Annamaria Musso; Carmela Ebba Buffone; Sarah Ottaviani; Paolo Bovi; Giuseppe Moretto
Journal:  Neurol Sci       Date:  2009-10-28       Impact factor: 3.307

3.  Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.

Authors:  Vasily Vorobyov; Frank Sengpiel
Journal:  Exp Brain Res       Date:  2008-08-06       Impact factor: 1.972

4.  Alpha and beta EEG power reflects L-dopa acute administration in parkinsonian patients.

Authors:  Jean-Marc Melgari; Giuseppe Curcio; Francesca Mastrolilli; Gaetano Salomone; Laura Trotta; Mario Tombini; Lazzaro di Biase; Federica Scrascia; Rita Fini; Emma Fabrizio; Paolo Maria Rossini; Fabrizio Vernieri
Journal:  Front Aging Neurosci       Date:  2014-11-05       Impact factor: 5.750

5.  Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.

Authors:  Ryoji Naganuma; Ichiro Yabe; Megumi Takeuchi; Kirari Morishita; Shingo Nakane; Ryoken Takase; Ikuko Takahashi-Iwata; Masaaki Matsushima; Mika Otsuki; Hideaki Shiraishi; Hidenao Sasaki
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.